These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11147701)

  • 1. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival.
    Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM
    Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
    Han WR; Murray-Segal LJ; Mottram PL
    Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley A; Mandel TE
    Diabetes; 1998 Sep; 47(9):1399-405. PubMed ID: 9726227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporine.
    Burkhardt K; Charlton B; Mandel TE
    Transplantation; 1989 May; 47(5):771-5. PubMed ID: 2655212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats.
    Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG
    Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel TE; Dillon H; Koulmanda M
    Transpl Immunol; 1995 Sep; 3(3):265-72. PubMed ID: 8581416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice.
    Akita K; Ogawa M; Mandel TE
    Cell Transplant; 1994; 3(1):61-73. PubMed ID: 7512875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of hamster islet xenografts in mice under short-course treatment with nondepleting versus depleting anti-CD4 monoclonal antibodies.
    Lu X; Schulz M; Zihlmann HR; Borel JF
    Xenotransplantation; 1998 May; 5(2):154-63. PubMed ID: 9584829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells.
    Darby CR; Morris PJ; Wood KJ
    Transplantation; 1992 Sep; 54(3):483-90. PubMed ID: 1384184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
    Song HK; Alters SE; Fathman CG
    Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathymic inoculation of donor antigen: an ineffective strategy for prolonging xenograft survival.
    Tran HM; Patel A; Allen RD; O'Connell PJ
    Xenotransplantation; 1999 May; 6(2):147-54. PubMed ID: 10431792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
    Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
    Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.